A new approval for smallest defibrillation lead of its kind | Post-TAVR bleeding | Key details about reprocessed catheter recall

The OmniaSecure defibrillation lead from Medtronic is already approved for placement in the right ventricle. This latest approval covers the left bundle branch area, opening the door for conduction system pacing and other advanced techniques.

When it came to all-cause mortality and ischemic stroke, however, the two popular DOACs were associated with comparable outcomes. 

Back in February, the FDA expanded a recall of several reprocessed EP and ultrasound catheters due to a risk of contamination. The agency is now sharing additional information with the public.

The first FDA-approved pacing lead specifically developed for LBBAP is now being implanted throughout the United States. 

The new version of the PFA system is five times faster than the current catheter to improve workflow.

The new nPulse nanosecond pulsed field ablation system uses five‑second applications to create lesions. It does not require catheter repositioning.

Gore has officially acquired Conformal Medical, the company known for an investigational LAAO device that uses a proprietary foam implant. The transaction was first announced in January.